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Abstract 
Objective: To compare the incidence and severity of pregnancy-induced hypertensive disorders in twin pregnancy and in singleton 
gestation. Study design: Case-control study in the setting of a University HOspital. Each pregnancy of a consecutive series of 187 
twin pregnancies attending the antenatal c inic and booked before a gestational ge of 24 weeks was matched for maternal age, 
parity, and gestational ge at delivery with a singleton pregnancy delivered in the same year. Primary end points of the analysis 
of the course and outcome of pregnancy were pregnancy-induced hypertension a d proteinuric pre-eclampsia. Results: In the twin 
pregnancy group, 21% of patients met the criteria for the diagnosis of a pregnancy-induced hypertensive disorder, compared with 
13% in the singleton pregnancy group (P < 0.05). The difference was due to a significantly higher incidence of pregnancy-induced 
hypertension i twin (15%) than in singleton (6%) pregnancy (P < 0.05), in particular in nulliparous women. The incidence of pre- 
eclampsia was similar in twin (6%) and singleton pregnancies (6.5%), without a difference in severity and in the occurrence ofthe 
HELLP syndrome. Conclusion: The incidence of non-proteinuric pregnancy-induced hypertension, but not of proteinuric pre- 
eclampsia, is increased in twin pregnancy. 
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1. Introduction 
The majority of published reports on complications of
twin pregnancy show an increase in the incidence of 
hypertensive disorders, which tend to occur earlier and 
to run a more severe course than in singleton gestation. 
Incidences of 20-30% are reported, 3-5 times higher 
than in singleton pregnancies [1-3]. Unfortunately, the 
older studies in particular lack adequate control groups 
and the criteria used to define hypertensive disease vary 
markedly [3,4-8]. In some cases no distinction is made 
between pregnancy associated with hypertension al- 
ready existing before pregnancy and pregnancy-induced 
hypertensive disorders, with or without proteinuria 
[4-8]. In addition, many reports do not distinguish 
between proteinuric pre-eclampsia, with its increased 
maternal and fetal risks, and non-proteinuric preg- 
nancy-induced hypertension, the main risk of which is 
the development of pre-eclampsia [9]. A reliable assess- 
ment of the risk of pregnancy-induced hypertensive 
disease in twin pregnancy has become ven more rele- 
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vant since evidence has become available that a low dose 
of aspirin may prevent he development of early-onset 
pre-eclampsia with preterm delivery in pregnancies at 
high risk [10,11], which could include multiple preg- 
nancy. 
The present study was designed to assess the incidence 
and severity of hypertensive disorders in twin pregnancy 
in a consecutive s ries of 187 patients attending the ante- 
natal clinic of the University Hospital Rotterdam- 
Dijkzigt from early in pregnancy. Strict definitions were 
applied and the results were compared with those in a 
control group of an equal number of women with 
singleton pregnancies, matched for maternal age, parity 
and gestational ge at delivery. 
2. Materials and methods 
All charts of patients with a twin pregnancy delivered 
in the University Hospital Rotterdam-Dijkzigt during 
the 10-year period between 1983 and 1992 were review- 
ed. Of the 447 patients, 187 were booked in our ante- 
natal clinic before a gestational age of 24 weeks and 
remained under our care until after delivery. The 
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remaining 260 patients were referred to our hospital 
after 24 weeks gestation for various maternal or fetal 
complications, including hypertensive disorders, and 
were not included in the study. Each twin pregnancy was 
matched for parity, maternal age (to within 2 years), and 
gestational age at delivery (within 1 week) with a 
singleton pregnancy, under our antenatal care before 24 
weeks' gestation and delivered in the same year as the 
index case. The matching was done by determining in a 
blinded fashion without knowledge of the course and 
outcome of pregnancy the first singleton delivery that 
was registered before or after the birth of a pair of twins 
and that met all matching criteria. 
Primary end points of the analysis of course and out- 
come of pregnancy in both groups were the occurrence 
of pregnancy-induced hypertension (PIH) and pre- 
eclampsia. Based on the recommendations of the Inter- 
national Society for the Study of Hypertension i Preg- 
nancy [12], PIH was defined as the occurrence after 20 
weeks gestation in a previously normotensive woman of 
a diastolic blood pressure of 90 mmHg or more, deter- 
mined in sitting position at Korotkoff 4 on two occa- 
sions at least 4 h apart. PIH with proteinuria of 0.3 g/1 
or more in a 24-h urine collection period exclusive of 
urinary infection or contamination was considered pre- 
eclampsia. A diagnosis of the syndrome of hemolysis, 
elevated liver enzymes, and a low platelet count 
(HELLP) was made in pre-eclamptic patients with he- 
molysis in a peripheral smear, serum levels of aspartate 
aminotransferase (ASAT) and alanine aminotransferase 
(ALAT) greater than 30 U/I, and a platelet count of less 
than 100 x 109/1. Superimposed pre-eclampsia was 
defined as proteinuria developing for the first time dur- 
ing pregnancy in a woman with chronic hypertension. 
Perinatal mortality was used as a subsidiary end 
point, and defined as the sum of all fetal deaths with a 
birthweight of 500 g or more and neonatal deaths of 500 
g or more within 28 days after birth per 1000 births. We 
defined the birthweight ratio as the quotient of the ac- 
tual birthweight of the infant and the expected birth- 
weight on the 50th percentile of the Dutch intrauterine 
growth curve for singleton pregnancies corrected for 
gestational ge, sex and parity [13]. All twin placentae 
were macroscopically and histologically examined, but 
investigations to establish zygosity such as blood group 
determination or HLA tissue typing were not routinely 
done. Twin pairs with a monochorionic placenta were 
classified as certainly monozygotic, and all unlike-sex 
twin pairs were classified as certainly dizygotic. Based 
on Weinberg's [14] hypothesis that for every pair of 
unlike-sex dizygotic twins there will be one like-sex pair, 
the estimated number of monozygotic twins was 
calculated by substra~ting the total number of unlike- 
sex twin pairs from the number of like-sex pairs. 
Data are presented as median and range throughout. 
Differences in continuous variables were assessed with 
Wilcoxon's rank sum test for comparison between 
groups, and discrete data were analysed with the x 2- 
test. A two-tailed probability level of 0.05 or less was 
considered to represent statistical significance. 
3. Results 
Clinical characteristics and outcome of the 187 
predominantly white women with twin and singleton 
pregnancies are summarized in Table 1. 
Because of the matching criteria used there are no dif- 
ferences with respect o maternal age, parity and gesta- 
tional age at delivery. We observed no significant 
difference between twin pregnancies and singleton con- 
trols in gestational ge at the first antenatal visit, and in 
cesarean section rate. There are no significant differ- 
ences between the birthweights of first and second twins; 
the birthweight ratios of twins are significantly lower 
than those of singletons (P < 0.05). 
The incidence of hypertensive disorders in twin and 
singleton pregnancies i  summarized in Table 2. In the 
twin group 21% met the criteria for diagnosis of a 
pregnancy-induced hypertensive disorder, as compared 
with 13% in the singleton group (P < 0.05). The differ- 
ence is due to a significantly higher incidence of PIH in 
twin than in singleton pregnancies, in particular in 
nulliparous women, whereas the incidence of pre- 
eclampsia is not different between twin pregnancies and 
singleton controls. Severe pre-eclampsia (proteinuria > 
5 g/l, or HELLP) occurred in eight of 187 women with 
a twin pregnancy compared with 10 of 187 controls, a 
non-significant difference. Eclampsia was not observed 
in either group. The median highest diastolic blood pres- 
sure before delivery in the twin pregnancies was 80 
mmHg (range, 55-130 mmHg), not different from the 
median highest diastolic blood pressure in the singleton 
pregnancy group of 80 mmHg (range, 55-150 mmHg). 
The incidence of pregnancy-induced hypertensive dis- 
orders in certainly dizygotic twin pregnancies (31/134) 
was not different from that in certainly or estimated 
monozygotic twin pregnancies (11/49). The median in- 
terval between the diagnosis of PIH and delivery in twin 
pregnancy (14 days) was twice that in singleton preg- 
nancy (7 days), but the difference is not statistically dif- 
ferent; the same is true for the interval between the 
diagnosis of pre-eclampsia and delivery in twin (12 days) 
and singleton (18 days) gestation. The hypertensive di- 
sorder was the main indication for termination of preg- 
nancy by induction of labor or cesarean section in 10 
twin pregnancies (five PIH, five pre-eclampsia) com- 
pared with 11 singleton pregnancies (five PIH, six pre- 
eclampsia). The median gestational age at termination 
of pregnancy for this indication was 37 (32-40) weeks in 
twin pregnancies and 34 (28-36) weeks in singletons (P 
< 0.05). Birthweight ratios in twin pregnancies com- 
plicated by PIH (median, 0.86; range, 0.70-1.02) were 
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orders in twin and singleton pregnancies are in general 
agreement with those obtained in other large series of 
twin pregnancies and singleton controls [2,3,8]. How- 
ever, the definition of hypertensive disease in pregnancy 
varies greatly in those reports, in particular with regard 
to the presence or absence of proteinuria, an important 
determinant of the severity of the disease and of preg- 
nancy outcome [15]. In our series the higher proportion 
of hypertensive disease in twin pregnancies i due to 
pregnancy-induced hypertension, whereas the incidence 
of proteinuric pre-eclampsia is not different from that in 
singleton pregnancy. In a population study in Aberdeen 
MacGillivray [2] found that the incidence of pre- 
eclampsia in the first pregnancy was five times greater in 
twin than in singleton pregnancies. Nylander and 
MacGillivray [16] examined the incidence of pre- 
eclampsia in twin pregnancies in Ibadan and found only 
4.5% in all parities compared with 6% in singletons. 
However, when they considered first pregnancies only, 
the rates were 5.9% and 1.1% for twin and singleton 
pregnancies, respectively. An extremely high incidence 
of 30% of proteinuric pre-eclampsia was observed in 
black African women with twin pregnancy [17]. Part of 
the differences may be explained by geographical varia- 
tion in the prevalence of hypertensive disorders, but the 
majority of reports in the literature cannot be used for 
international comparison. The elevated incidence of pre- 
eclampsia in twin pregnancy in hospital-based studies 
[3,8] could be due, at least in part, to selection bias, be- 
cause patients with pre-eclampsia may be more easily 
referred to a tertiary care center than women with PIH 
alone. For that reason we included in our study only 
women who were under our antenatal care before 24 
weeks' gestation. Some studies have found a higher inci- 
dence of pre-eclampsia n unlike-sex than in like-sex 
twin pregnancies, which would suggest an immunologi- 
cal cause due to maternal-fetal ntigenic differences in 
dizygotic twin pregnancy [18]. Other studies, however, 
found higher rates of pre-eclampsia ssociated with 
monozygotic as compared with dizygotic twins [17] or 
no differences [19]. Also, in our study no influence of 
zygosity on the incidence of pregnancy-induced hyper- 
tensive disorders was apparent, but the numbers are 
relatively small. 
A greater proportion of singleton than of twin preg- 
nancies may be expected to continue until term, and so 
more singleton than twin pregnancies will be at risk of 
developing a pregnancy-induced hypertensive disorder 
later in pregnancy. For that reason we matched for 
gestational ge at delivery. However, in twins preterm 
delivery is often caused by the condition of multiple 
pregnancy itself, whereas in singleton pregnancies a 
higher proportion of preterm deliveries may be at- 
tributable to induction of labor for a hypertensive disor- 
der. This was indeed observed in our study and would 
tend to introduce a bias towards a higher incidence of 
pre-eclampsia in singleton pregnancy with a smaller dif- 
ference in hypertensive disorders between twins and 
singletons. 
The increased incidence of non-proteinuric PIH in 
twin pregnancies in our study could be due to the higher 
cardiac output and circulating plasma volume [20,21] in 
multiple pregnancies compared with singleton gesta- 
tions. If we accept hat in twin pregnancy cardiac output 
is increased by heart rate, compared with singleton preg- 
nancy [20], as well as by stroke volume, in particular in 
the third trimester [21], the occurrence of PIH may be 
explained by failure to decrease peripheral vascular e- 
sistance any further when the physiologic limit for 
singleton pregnancy has been reached. In that case nor- 
mal organ perfusion would be maintained, and the 
endothelial damage associated with reduced perfusion in 
pre-eclampsia [22] would not be expected to occur. The 
finding that birthweight ratios in twin pregnancies with 
PIH were equal to those in normotensive twin pregnan- 
cies supports this hypothesis. 
There is no doubt that multiple pregnancy is associ- 
ated with greater risks for both mother and fetuses com- 
pared with singleton pregnancy, but our study failed to 
substantiate an increased risk of proteinuric pre- 
eclampsia in a cohort of predominantly white women 
with twin pregnancies. 
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Table 1 
Clinical characteristics and outcome of pregnancy in twin and singleton pregnancies 
11 
Twin pregnancy (n = 187) Singleton pregnancy (n = 187) 
Median (range) n Median (range) 
Maternal age (years) 30 (17-47) 
Nulliparous 103 
Parous 84 
Gestational age at first antenatal 14 (6-23) 
visit (weeks) 
Gestational age at delivery 37 (21-41) 
(weeks) 
Mode of delivery 
Vaginal 
Lower segment cesarean section 
Birthweights (g) 
First born 2375 (140-3715) 
Second born 2338 (130-3660) 
Birthweight ratio 
First born 0.87 (0.23-1.58) 
Second born 0.84 (0.12-1.23) 
Perinatal mortality (°/oo) 58.8 
Fetal deaths 2 
Neonatal deaths 20 
Zygosity 
Certainly monozygotic 39 
Certainly dizygotic 134 
















not different from those in normotensive twin pregnan- 
cies (median, 0.88; range, 0.23-1.58), but somewhat 
higher than those in twin pregnancies with pre- 
eclampsia (median 0.84, range 0.68-0.98), although the 
difference was not significant. 
The perinatal mortality rate in twins was twice that in 
singletons (P < 0.05) due to a higher number of neo- 
natal deaths associated with lethal congenital abnormal- 
ities (n = 2) and complications of twin-to-twin 
Table 2 
Incidence of hypertensive disorders in twin and singleton pregnancies 
transfusion (n = 6). In the twin group two of the peri- 
natal deaths occurred in the 11 patients with pre- 
eclampsia, whereas one perinatal death occurred in the 
12 pre-eclamptic singleton pregnancies. 
4. Discussion 
The results of our matched-pair comparative study on 
the incidence of all pregnancy-induced hypertensive dis- 
Twin pregnancy Singleton pregnancy 
Nulliparous Parous Total Nulliparous Parous Total 
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n % n % n % n % n % n % 
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Hypertensive 30 (29) 12 (14) 42 (22.4)* 18 (18) 11 (13) 29 (15.5) 
PIH 20 (19) 8 (10) 28 (15.0)* 5 (5) 7 (8) 12 (6.4) 
Pre-eclampsia 7 (7) 1 (1) 8 (4.2) 8 (8) 0 8 (4.2) 
Pre-eclampsia + HELLP 2 (2) 0 2 (1.1) 2 (2) 0 2 ( 1.1 ) 
Chronic hypertension 1 (1) 2 3 (1.6) 1 (1) 4 (5) 5 (2.7) 





*P < 0.05 compared with singleton pregnancy 
J.G, Santema et al./ European Journal of Obstetrics & Gynecology and Reproductive Biology 58 (1995) 9-13 13 
[14] Weinberg W. Differenzmethode und Geburtenfolge bei Zwill- 
ingen. Genetica 1934; 16: 282-288. 
[15] Wallenburg HCS. Detecting hypertensive disorders in preg- 
nancy. In: Chalmers I, Enkin M, Keirse MJNC, eds. Effective 
care in pregnancy and childbirth, vol. 1. Oxford: Oxford Univer- 
sity Press, 1989; 382-402. 
[16] Nylander PP, MacGillivray I. Complications oftwin pregnancy. 
In: Human multiple reproduction. London: WB Saunders, 1969; 
137-146. 
[17] McMullan PF, Norman RJ, Marivate M. Pregnancy-induced 
hypertension i twin pregnancy. Br J Obstet Gynaecol 1984; 91: 
240-243. 
[18] Stevenson AC, Davidson BCC, Say B et al. Contribution of 
fetal/maternal incompatibility oaetiology of pre-eclamptic tox- 
aemia. Lancet 1971; ii: 1286-1289. 
[19] Campbell DM, McGillivray I, Thompson B. Twin zygosity and 
pre-eclampsia. Lancet 1977; ii: 97. 
[20] Robson SC, Hunter S, Boys R J, Dunlop W. Hemodynamic 
changes during twin pregnancy. A Doppler and M-mode echo- 
cardiographic study. Am J Obstet Gynecol 1989; 161: 
1273-1278. 
[21] Veille JC, Morton MJ, Burry KJ. Maternal cardiovascular 
adaptations totwin pregnancy. Am J Obstet Gynecol 1985; 153: 
261-263. 
[22] Roberts JM, Redman CWG. Pre-eclampsia: more than 
pregnancy-induced hypertension. Lancet 1993; 341: 1447-1454. 
